LU103185B1 - Gmo-free composition of reduction of food-borne toxins and production method thereof - Google Patents
Gmo-free composition of reduction of food-borne toxins and production method thereof Download PDFInfo
- Publication number
- LU103185B1 LU103185B1 LU103185A LU103185A LU103185B1 LU 103185 B1 LU103185 B1 LU 103185B1 LU 103185 A LU103185 A LU 103185A LU 103185 A LU103185 A LU 103185A LU 103185 B1 LU103185 B1 LU 103185B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- food
- composition
- component
- acid
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 191
- 239000003053 toxin Substances 0.000 title claims abstract description 87
- 231100000765 toxin Toxicity 0.000 title claims abstract description 82
- 108700012359 toxins Proteins 0.000 title claims abstract description 81
- 230000009467 reduction Effects 0.000 title claims abstract description 37
- 238000004519 manufacturing process Methods 0.000 title description 25
- 235000013305 food Nutrition 0.000 claims abstract description 140
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 103
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 92
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 claims abstract description 46
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 claims abstract description 44
- 150000003839 salts Chemical class 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 40
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 32
- 239000000126 substance Substances 0.000 claims abstract description 32
- 230000002378 acidificating effect Effects 0.000 claims abstract description 25
- 239000000654 additive Substances 0.000 claims abstract description 23
- 238000012545 processing Methods 0.000 claims abstract description 16
- 230000000996 additive effect Effects 0.000 claims abstract description 15
- 235000013373 food additive Nutrition 0.000 claims abstract description 13
- 239000002778 food additive Substances 0.000 claims abstract description 13
- 235000021067 refined food Nutrition 0.000 claims abstract description 7
- 235000021474 generally recognized As safe (food) Nutrition 0.000 claims abstract 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 claims abstract 2
- 239000002253 acid Substances 0.000 claims description 55
- 235000016213 coffee Nutrition 0.000 claims description 52
- 235000013353 coffee beverage Nutrition 0.000 claims description 52
- 150000001450 anions Chemical class 0.000 claims description 48
- 230000015572 biosynthetic process Effects 0.000 claims description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 34
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 150000001768 cations Chemical class 0.000 claims description 25
- 229910052751 metal Inorganic materials 0.000 claims description 25
- 239000002184 metal Substances 0.000 claims description 25
- 229910014585 C2-Ce Inorganic materials 0.000 claims description 20
- -1 amino, hydroxy Chemical group 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 235000015165 citric acid Nutrition 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 11
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 10
- 235000011090 malic acid Nutrition 0.000 claims description 10
- 239000001630 malic acid Substances 0.000 claims description 10
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 8
- 239000002197 FEMA number Substances 0.000 claims description 8
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 235000002906 tartaric acid Nutrition 0.000 claims description 8
- 239000011975 tartaric acid Substances 0.000 claims description 8
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 8
- 235000021374 legumes Nutrition 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 5
- 235000018417 cysteine Nutrition 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000015203 fruit juice Nutrition 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 235000015895 biscuits Nutrition 0.000 claims description 4
- 235000008429 bread Nutrition 0.000 claims description 4
- 235000015496 breakfast cereal Nutrition 0.000 claims description 4
- 235000020965 cold beverage Nutrition 0.000 claims description 4
- 235000014510 cooky Nutrition 0.000 claims description 4
- 235000012495 crackers Nutrition 0.000 claims description 4
- 235000012438 extruded product Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 4
- 235000014571 nuts Nutrition 0.000 claims description 4
- 235000012015 potatoes Nutrition 0.000 claims description 4
- 235000012433 rusks Nutrition 0.000 claims description 4
- 238000007669 thermal treatment Methods 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 235000012431 wafers Nutrition 0.000 claims description 4
- 241000207836 Olea <angiosperm> Species 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 235000012171 hot beverage Nutrition 0.000 claims description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 3
- 235000021317 phosphate Nutrition 0.000 claims description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 3
- 235000013573 potato product Nutrition 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229940001468 citrate Drugs 0.000 claims description 2
- 229940001447 lactate Drugs 0.000 claims description 2
- 229940049920 malate Drugs 0.000 claims description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
- 229940095064 tartrate Drugs 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 abstract description 15
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 239000000306 component Substances 0.000 description 120
- 150000001875 compounds Chemical class 0.000 description 71
- 240000007154 Coffea arabica Species 0.000 description 58
- 239000000047 product Substances 0.000 description 48
- 235000002639 sodium chloride Nutrition 0.000 description 38
- 239000000243 solution Substances 0.000 description 37
- 238000009472 formulation Methods 0.000 description 33
- 235000003869 genetically modified organism Nutrition 0.000 description 25
- 230000001603 reducing effect Effects 0.000 description 23
- 150000007513 acids Chemical class 0.000 description 21
- 230000008569 process Effects 0.000 description 21
- 230000008901 benefit Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 230000001105 regulatory effect Effects 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 14
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 13
- 244000046052 Phaseolus vulgaris Species 0.000 description 13
- 238000007792 addition Methods 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- 102000015790 Asparaginase Human genes 0.000 description 12
- 108010024976 Asparaginase Proteins 0.000 description 12
- 229960003272 asparaginase Drugs 0.000 description 12
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 11
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 235000007460 Coffea arabica Nutrition 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 150000001735 carboxylic acids Chemical class 0.000 description 8
- 235000012777 crisp bread Nutrition 0.000 description 8
- 235000012432 gingerbread Nutrition 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 235000019260 propionic acid Nutrition 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229960005069 calcium Drugs 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 235000011056 potassium acetate Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 235000011054 acetic acid Nutrition 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 235000013312 flour Nutrition 0.000 description 6
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000011002 quantification Methods 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000001354 calcium citrate Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000010411 cooking Methods 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 235000009582 asparagine Nutrition 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 235000011092 calcium acetate Nutrition 0.000 description 4
- 239000001639 calcium acetate Substances 0.000 description 4
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 4
- 150000001767 cationic compounds Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000013068 control sample Substances 0.000 description 4
- 230000003292 diminished effect Effects 0.000 description 4
- 235000010855 food raising agent Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 235000005772 leucine Nutrition 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 4
- 235000010265 sodium sulphite Nutrition 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 235000013337 tricalcium citrate Nutrition 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 229960005147 calcium acetate Drugs 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000021472 generally recognized as safe Nutrition 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000009877 rendering Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 3
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000001358 L(+)-tartaric acid Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 239000004330 calcium propionate Substances 0.000 description 2
- 235000010331 calcium propionate Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- GBAOBIBJACZTNA-UHFFFAOYSA-L calcium sulfite Chemical compound [Ca+2].[O-]S([O-])=O GBAOBIBJACZTNA-UHFFFAOYSA-L 0.000 description 2
- 235000010261 calcium sulphite Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 235000007983 food acid Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229910052755 nonmetal Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000013348 organic food Nutrition 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 235000011085 potassium lactate Nutrition 0.000 description 2
- 239000001521 potassium lactate Substances 0.000 description 2
- 239000001472 potassium tartrate Substances 0.000 description 2
- 235000011005 potassium tartrates Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 239000004324 sodium propionate Substances 0.000 description 2
- 235000010334 sodium propionate Nutrition 0.000 description 2
- 239000001433 sodium tartrate Substances 0.000 description 2
- 235000011004 sodium tartrates Nutrition 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 239000001244 (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)pent-1-en-3-one Substances 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- SFOKDWPZOYRZFF-UHFFFAOYSA-H 2,3-dihydroxybutanedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O SFOKDWPZOYRZFF-UHFFFAOYSA-H 0.000 description 1
- 239000001838 2,4-dimethyl-6-propan-2-yl-1,3,5-dithiazinane Substances 0.000 description 1
- JLLRXSCNTCSLFX-UHFFFAOYSA-H 2-hydroxybutanedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C(O)CC([O-])=O.[O-]C(=O)C(O)CC([O-])=O.[O-]C(=O)C(O)CC([O-])=O JLLRXSCNTCSLFX-UHFFFAOYSA-H 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QVYAWBLDJPTXHS-UHFFFAOYSA-N 5-Hydroxymethyl-2-furfural Natural products OC1=CC=C(C=O)O1 QVYAWBLDJPTXHS-UHFFFAOYSA-N 0.000 description 1
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 241000723554 Pontia occidentalis Species 0.000 description 1
- 231100000766 Possible carcinogen Toxicity 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001372 asarum canadense l. root oil Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052728 basic metal Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000011001 calcium citrates Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- UZLGHNUASUZUOR-UHFFFAOYSA-L dipotassium;3-carboxy-3-hydroxypentanedioate Chemical compound [K+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O UZLGHNUASUZUOR-UHFFFAOYSA-L 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 231100000003 human carcinogen Toxicity 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000001847 methyl (E)-hex-2-enoate Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000015861 monopotassium citrate Nutrition 0.000 description 1
- 239000002444 monopotassium citrate Substances 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 238000009329 organic farming Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- 239000001415 potassium malate Substances 0.000 description 1
- 235000011033 potassium malate Nutrition 0.000 description 1
- SVICABYXKQIXBM-UHFFFAOYSA-L potassium malate Chemical compound [K+].[K+].[O-]C(=O)C(O)CC([O-])=O SVICABYXKQIXBM-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- WKZJASQVARUVAW-UHFFFAOYSA-M potassium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WKZJASQVARUVAW-UHFFFAOYSA-M 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000011091 sodium acetates Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000017454 sodium diacetate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/145—Acids, anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/02—Treating green coffee; Preparations produced thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
- A23L5/276—Treatment with inorganic compounds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
The present invention discloses an acidic composition as an additive in thermally processed food items. The composition comprises a dual-component mixture with a first component, a salt, and a second component, an organic C2-C6 carboxylic acid. The composition is characterized by being leavening-free, non-GMO, and coating-free, and it effectively reduces food-related toxins produced during thermal food processing. The toxin reduction includes acrylamide, furan and hydroxymethylfurfural. The ingredients may be approved food additives and/or GRAS substances and the present invention describes methods of making the composition and using it in various food items, and/or beverages to reduce foodborne toxins during thermal processing.
Description
GMO-FREE COMPOSITION FOR REDUCTION OF FOOD-BORNE TOXINS AND PRODUCTION LU1 03188
METHOD THEREOF +
TECHNICAL AREA oD
The present invention relates to an acidic composition for reducing foodborne toxins according = © to claim 1, and further discloses a method for its production. Preferably, the composition can SA effectively reduce acrylamide, furan and hydroxymethylfurfural (HMF) contained and/or formed * Na in thermally processed food items, employing a dual-component mixture, without the use of S compounds derived from genetically modified organisms (GMOs) and is free of additional additives such as leavening agents and coatings.
STATE OF THE ART
Food-borne toxins, which are harmful substances contaminating food, can lead to a variety of illnesses upon consumption. These detrimental substances can originate from numerous sources, such as bacteria, molds, viruses, and sometimes even the food products themselves.
Certain food-borne toxins are naturally present, for example, some mycotoxins that are produced by molds. Others, however, result from microbial infection or food spoilage.
Furthermore, there is a category of food-borne toxins that develop during food processing. In this case, starting materials, initially non-toxic, undergo transformations that lead to the creation of toxic compounds, thus underlining the importance of proper food processing and handling practices. A prime illustration of the generation of food-borne toxins during food processing emerges when heat treatment is applied to a variety of food products.
Acrylamide (CsHsNO) is a potentially harmful compound that forms in certain types of food during high-temperature cooking processes, such as frying, roasting, and baking at high temperatures especially above 180°C. The formation of acrylamide is predominantly due to a process known as the Maillard reaction, which is a chemical reaction between amino acids and sugars that occurs when food items are heated. More specifically, acrylamide forms from a reaction between the amino acid asparagine and reducing sugars such as glucose and fructose present in food. Starchy foods, such as potatoes and grain products, are particularly prone to acrylamide formation when they're cooked at high temperatures, due to their higher levels of asparagine and reducing sugars, the two key ingredients for acrylamide formation.
Other factors effecting high levels of acrylamide in foods are a low moisture content, a high pH level and increased cooking durations. Another compound formed during thermal treatment of carbohydrate-rich foods is 5-Hydroxymethyl 2-furfural (HMF; CeHeOs). Its formation is white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application particularly associated with the Maillard reaction and the acid-catalyzed dehydration of LU10318% hexoses such as glucose and fructose. Factors like high temperatures and low pH significantly + influence its creation. HMF is prevalent in foods like honey, fruit juices, baked goods, and heat- oo treated milk, with quantities varying based on the food type and preparation method. Another Te compound associated with the Maillard reaction and known as a thermally induced food-borne 2 © toxin is furan (C4H4O), along with its derivatives such as 2-methylfuran (CsHsO) and 3- = ® methylfuran (CsHeO). Beyond the Maillard reaction, furan can form through alternative > pathways such as the thermal degradation of natural food components like vitamin C, as well S ee as through the oxidation of polyunsaturated fats. ve
Ever since the detection of food-borne toxins such as acrylamide, HMF, and furans in the 20th and 21st century, their toxicity especially in terms of carcinogenicity and associated risks have been well-established. Thanks to the continual improvement in analytical detection methods, it has been revealed that these substances are prevalent in a magnitude of products in our food supply. As a result, chronic exposure to these toxins is almost unavoidable, leading to both a rising consumer demand and a regulatory push aiming to reduce the level of these harmful compounds in our food. In April 2018, the European Commission Regulation (EU) 2017/2158 established mitigation measures and benchmark levels for the reduction of acrylamide in food, with binding thresholds expected for 2024. Despite the absence of formal binding thresholds for acrylamide in the United States, food producers still face challenges, as acrylamide has been classified as a potential carcinogen under California's Proposition 65 since 1990, necessitating a warning label on products sold in California that contain acrylamide, wherefore producers aiming to penetrate the U.S. market must inherently adhere to these specifications. Other regions, including Australia, New Zealand, and China, have started scrutinizing the issue of food-borne toxins. Consequently, future regulations intended to limit their presence in food can be anticipated. Regarding furan and HMF, ongoing risk analyses are being conducted globally, and the increasing body of evidence suggests that future measures may be instituted to limit these compounds in food. For instance, the
European Food Safety Authority (EFSA) conducted an extensive evaluation of the health risks associated with furan in food and published its findings in 2017, whilst the Food and Drug
Administration (FDA) in the United States progressively formulated a Furan Action Plan over the span of 2005 to 2007.
To tackle food-borne toxins that arise from thermal processing, both legislators and private companies have advocated and developed numerous mechanical and physical strategies for reducing these substances in food. These include pre-treatment measures like cold storage of produce to reduce sugar content or blanching, soaking, and rinsing to eliminate asparagine, a white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application key precursor to acrylamide; adaptations to the cooking process, such as employing lower LU10318% temperatures, reducing cooking durations, or utilizing methods like microwave cooking or + steaming; and post-treatment techniques like vacuum application to remove acrylamide from oo the final product. However, these strategies often necessitate investment in additional Te equipment and modifications to existing processes and may not be universally applicable. 2 ©
Therefore, many food producers, particularly those dealing with acrylamide-prone products, = @ have advocated for incorporating ingredients into their recipes that can decrease food-borne toxins in the final product, eliminating the need for substantial process alterations and investments. S
Enzymatic strategies, as outlined in the patent document US20070166439A1 and available commercially through companies like Novozymes (Acrylaway®) or DSM (PreventASe®), are among the most favored ingredient to reduce acrylamide in food. Alternatively, asparaginase rich baker's yeast products commercially available through companies like Kerry Group (Acryleast"") utilize the same mode of action. These strategies employ asparaginase to lower the quantity of asparagine, a precursor to acrylamide, in foods. Nevertheless, asparaginase, is produced using genetically modified organisms (GMOs), limiting its use in foods requiring a
GMO-free label, as well as in organic products, both in the United States and the European
Union. Furthermore, despite the need for only small quantities, asparaginase remains an expensive ingredient. Its application also necessitates longer pretreatment times in the food substrate to ensure its effectiveness, increasing stand times, further escalating the production costs for food manufacturers. Moreover, the effectiveness of enzymes is subject to environmental factors such as pH and temperature, leading to a high dependency on precise storage and transport temperatures, as well as adequate food product formulations for optimal performance, rendering the unpredictability and high variance of asparaginase results, adding to the complexity of this solution. Despite some asparaginase rich baker’s yeast products being available in GMO-free versions intensified application downsides prevail whilst complications through the leavening activity of the baker’s yeast can arise, rendering this product unsuitable for a multitude of bakery products. The patent document US20070141225A1 seeks to enhance the reliability of asparaginase by integrating additional components such as multivalent cationic salts, food acids, food bases, and amino acids. However, given that asparaginase is the primary ingredient, the previously noted challenges associated with asparaginase still persist.
Moreover, the patent does not allow the product to be offered as a premix. This limitation arises because many of the outlined secondary components, including the specified food acids and bases, are incompatible with asparaginase in a premix, as asparaginase is susceptible to environmental changes, such as shifts in pH, which can compromise its stability and effectiveness. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
The inclusion of multivalent cationic salts, as proposed in patent documents Te
US20050079254A1 and US20070212450A1, is intended as a method to replace the use of 2 © enzymes in food as acrylamide reducing agents. However, the use of salts and double salts = @ alone presents limited effectiveness in reducing acrylamide formation. This limitation stems from the fact that only a restricted number of Maillard pathways are impacted, given that these S se additions do not induce any change in the environmental pH conditions. Moreover, these S patent documents solely address the issue of acrylamide in food products while neglecting other harmful substances such as hydroxymethylfurfural (HMF) and furan.
Patent documents JP2005021150A and WO2004075655A2 discuss methods for reducing acrylamide levels in food products by using a mixture of various amino acids and their salts.
Although the patents propose potential benefits, they include a composition that integrates a mix of amino acids, some of which carry high costs. This aspect detracts from the appeal of the solution and could benefit from the introduction of a secondary component that utilizes more economically viable compounds. An additional limitation is the fact that several amino acids named in the patents lack approval for use in food production, with none of the products mentioned for use in organic goods within the European Union, significantly restricting the feasibility of the suggested solution in this crucial market. The patents’ use of certain amino acids like glutamine may exacerbate the issue, as amino acids that contain an amide group in their side chains can contribute to the Maillard reaction, potentially leading to an increase in acrylamide formation. Further, the patent documents only address the issue of acrylamide in food products, overlooking other harmful substances like hydroxymethylfurfural (HMF) and furan. These limitations drastically reduce the patents utility and the range of their potential applications.
Patent document DE102019113073A1 proposes utilizing a multivalent cationic carbonate as a primary component and an acidic compound as a secondary component to reduce acrylamide in food. However, the use of carbonates as the primary component has major issues: 1. Carbonates lead to an increase in the pH level of food, posing a risk of amplified acrylamide formation and rendering the secondary acidic component less useful. 2. Carbonates (component 1) exhibit a tendency to react with acidic compounds (component 2), resulting in the release of carbon dioxide. The patent proposes a fat coating to counteract this issue. However, this solution amplifies production costs and white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application compromises product efficiency, as the fat coating only melts upon the application of LU10318% heat, thus delaying efficacy in the food product. + 3. Carbonates are not universally applicable, especially in food mixtures not requiring os leavening or those employing yeast for leavening. This restriction challenges Te manufacturers already dealing with limited control over leavening power of their 2 © products. = ® te
Further, the patent document only addresses the issue of acrylamide in food products, A overlooking other harmful substances like hydroxymethylfurfural (HMF) and furan. Therefore, = there is still a significant need for a more effective strategy that can manage the presence of harmful substances in food production without compromising process efficiency and compound efficacy.
Patent documents KR102234633B1 and KR20090062381A propose the addition of different compounds including dicarbonyl trapping agents, reducing agents, water-soluble antioxidants, fat-soluble antioxidants, and proteins to reduce furan levels in food. However, the reliance on substances including epicatechin (EC), epigallocatechin gallate (EGCG), caffeic acid, ferulic acid, and coenzyme Q10 to curb furan formation, particularly in juices and coffee, poses significant challenges. Regulatory restrictions in many parts of the world, including the
European Union, do not permit the use of these substances in food. Additionally, the high cost and limited availability of these products further exacerbate the problem. While the patent mentions reducing other Maillard reaction products, it falls short in addressing the formation of acrylamide and HMF. Given the crucial importance to eliminate these compounds to ensure food safety, this reduces the patent's urgency and utility. Hence, a more effective strategy that balances food safety, process efficiency, and compound economics in managing harmful substances in food production is still in high demand. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
OBJECT OF THE INVENTION / TECHNICAL PROBLEM +
Amid rising consumer health consciousness and mounting regulatory pressures globally, the 2° food industry faces an urgent need for a practical and efficient solution to mitigate food-borne 2 S toxins. Of particular concern are toxins such as acrylamide, furan, and hydroxymethylfurfural, So nN of which a reduction is pivotal to adhere to food safety and quality standards. There exists an 3 & imperative necessity for a solution that surpasses the limitations of current alternatives to ss address these significant challenges effectively. Hence, the object of invention is to create an = We effective, cost efficient and robust solution, which is free of GMOs, free of additional additives such as leavening agents and coatings, easy and economical to implement, applicable to a wide array of products and adaptable to a variety of food-borne toxins.
A simple and cost-effective manufacturing process is also necessary, using readily available materials and requiring no additives or catalysts for large-scale economic synthesis. Moreover, ensuring easy usability that does not necessitate substantial alterations in the existing industrial processes is fundamental, as it would facilitate a swift and efficient adoption.
The object of invention has been solved through an acidic composition according to claim 1 for the use as additive in thermally processed food items, employing a at least dual-component mixture, comprising a first component, preferably an a C2-Ce mono- and/or di- and/or tri-valent carboxylic acid derived salt and/or oxyacid derived salt, and a second component, preferably an organic C2-Ce carboxylic acid, wherein the composition is leavening agent-, GMO- and coating-free and reduces food-borne toxins present and/or produced during thermal processing of food-items when applied.
In addition, the inventors disclose a process for preparing a composition according to claim 13, its use in the preparation of food-items according to claims 15-19, and a process for preparing toxin-reduced food-items using the composition according to claim 14.
Further advantageous embodiments and further embodiments result from the subclaims as well as from the description with reference to the figures. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
GENERAL ADVANTAGES LU1 0318
AS
Surprisingly, it has been discovered that incorporating a food additive acid composition = according to the current invention into food products can effectively and robustly reduce food- 2 borne toxins such as acrylamide, furan, and HMF, either individually or simultaneously, without 2 S the need for compounds derived from genetically modified organisms. This finding opens up So nN new markets where previous solutions involving GMO derivatives, prohibited ingredients in = & food, or unfeasible or uneconomical methods were not applicable. By concentrating on a ss solution solely aimed at reducing food-borne toxins, producers are given the flexibility to -_" incorporate any other functional ingredients at the necessary dose into the final product, without having to settle for subpar results in other domains.
The use of a buffered carboxylic acid system by incorporating a carboxylic acid or oxy acid salt as the first component and a carboxylic acid as a second component of the composition lowers the pH of the food-item, further suppressing the thermic induced Maillard reaction unlike when basic additives such as but not limited to carbonates are used as exemplified in the prior art.
Additionally, the herein disclosed composition is specifically designed not to contain any leavening agents, such as carbonates and yeasts, which are typically employed in the prior art to reduce acrylamide. The inclusion of these agents often leads to an unintended and unpredictable leavening of food products, making them unsuitable for foods that do not require leavening, a specific leavening style, or a precisely calibrated leavening strength. Further, carbonate-based approaches which include an acid component are unsuitable for soaking applications, as these would neutralize in solution.
Another advantage pertains to the distrust towards GMO-modified food, which as per recent surveys, is still met with skepticism by a significant portion of the public in many markets.
Beyond the economic benefits presented by this innovation, it could also bolster public health by diminishing the presence of hazardous food toxins. The use of the composition outlined in the current invention could potentially gain wider acceptance, thereby contributing positively to the general wellbeing of the public. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
DETAILED DESCRIPTION LUTOS18R
AS
The inventors provide an acidic composition, preferably a food additive acid composition as = additive in thermally processed food items, employing an at least dual-component mixture, 2 comprising a first component comprising at least a salt that comprises at least an anion, 2 S preferably a Cz-Cs mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or So nN oxyacid derived anion, and at least a metal cation; and a second component comprising an 3 & acid, preferably an organic C2-Ce carboxylic acid, wherein the composition is leavening agent- x N , GMO- and coating-free and reduces food-borne toxins produced during thermal processing, = We preferably in a temperature range between 80 and 400°C, of food-items when applied.
In a preferred embodiment, the first component consists of at least a salt that comprises at least an anion, preferably a C.-Cs mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived anion, and at least a metal cation. In an alternative embodiment, the salt consists of at least an anion, preferably a C,-Cs mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived anion, and at least a metal cation.
In a preferred embodiment, the second component consists of an acid, preferably an organic
C2-Ce carboxylic acid.
In a preferred embodiment, the first component consists of one salt. In another preferred embodiment, the first component consists of two salts.
In a preferred embodiment, the salt comprises one anion, preferably a C2-Ce mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived anion and at least a metal cation.
In other embodiments the salt comprises two anions, preferably a Cz-Cs mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived anion and least a metal cation.
In the spirit of this invention, the food additive acid composition, may be also referred to as composition, acidic composition or composition in accordance with the current invention.
A salt comprising at least an acid derived anion in the spirit of the current invention refers to a salt derived from the partial and/or complete neutralization of an acid with a metal and/or metal base. Preferably, the formed metal acid salts are acidic, neutral, or only slightly alkaline.
Carboxylates are anions derived from carboxylic acids. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
Anions are negatively charged ions formed when atoms gain electrons, commonly associated + with nonmetals, and play a key role in acids. Cations are positively charged ions formed when oo atoms lose electrons, typically associated with metals, and contribute to the formation of salts. Te
Acids are substances that release hydrogen ions (H”) when dissolved in water, with anions 2 © being crucial for their acidic behavior. Metals tend to form cations by losing electrons in = @ chemical reactions, often leading to the creation of ionic compounds and salts. In the spirit of this invention, anions are regarded as acids which have lost at least one hydrogen ion and therefore having at least one negative charge and cations are regarded as metals with a S positive charge. Preferably, an acid is completely neutralized, meaning that all acidic hydrogen atoms are replaced by metal cations. In an aspect related to organic acids (carboxylic acids), if an acid is mono-carboxylic, the resulting anion is mono-charged (monocarboxylate), if an acid is di-carboxylic, the resulting anion is di-charged (dicarboxylate), if the acid is tricarboxylic the resulting anion is tri-charged (tricarboxylate). Metal cations are positively charged ions.
An acidic substance is a chemical compound with a pH value in aqueous solution below 7. The pH scale ranges from O to 14, with 7 being neutral. Solutions below pH 7 are acidic, while that above pH 7 are alkaline or basic.
The addition of C:-Cs monocarboxylic, dicarboxylic, or tricarboxylic acid preferably substituted with an alkyl, amino, hydroxy, and sulfhydryl group, has been observed to decrease the levels of acrylamide, furan, and HMF in food. These acids, in a broader sense, are substances that donate protons (H* ions) and can lower the pH of a solution. pH is a measure of acidity or alkalinity based on the concentration of hydrogen ions.
When an acid is added to food or any other substance, it can modify its pH. The strength of the chemical bound hydrogen determines the strength of the acid and present in sufficient concentration, it can significantly decrease the pH, making the substance more acidic. In
Oxyacids, the strength of the H-O-bond and the stabilization of the negative charge by the structure determine the strength. Organic acids tend to have higher associated pH values than mineral acids, a class of inorganic acids.
A substance, mixture or composition in accordance with the current invention is acidic when the pH-Value of a dilute solution, preferably 10 wt%, of the mixture in water is below pH = 7, more preferably below pH = 6, most preferably below pH = 5.5. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
A carboxylic acid in the spirit of the current invention is any substance containing at least one LU10318% carboxyl functional group (-COOH), a monovalent contains one, a divalent two and a trivalent + acid contains three carboxyl functional groups. oo
Oxyacids, also known as oxoacids, are a type of acid that contain oxygen, hydrogen, and one fy ond or more other elements. These acids are characterized by the presence of one or more oxygen = @ atoms bonded to a central atom (usually a nonmetal). They can have several H-O-groups, which influence their acidity. S ee “on
Inthe spirit of the current invention, all oxyacids follow this general structure formula: (HO).XR, wherein n is a natural number < 3 and X is an atom or a group of atoms with exception of C, e.g., carboxylic acids and carbonic acid are excluded.
GMO stands for genetically modified organisms. It refers to any living organism whose genetic material (DNA) has been altered by genetic engineering techniques. These changes are made in a laboratory to introduce certain traits or characteristics that may not occur naturally in the organism through conventional breeding methods. GMO foods, also referred to as genetically modified (GM) foods, are products derived from genetically engineered plants or organisms.
These foods are produced by inserting or removing certain genes from the DNA of plants, animals, or microorganisms.
GMO-free means that no component of the composition, especially preferably the first and second component are not produced with and/or derived from a GMO modified organism.
Controversy over safety, environmental impacts, and potential human health effects has led many consumers to be critical of food items containing or produced from GMOs, resulting in an economic advantage to the composition.
In some preferred embodiments, the individual compounds specified in the invention offer exceptional value due to their readily available and cost-effective nature. Moreover, the disclosed compounds are available as non-GMO versions, which aligns with the increasing consumer demand for GMO-free options.
Consumer demand for GMO-free options has been on the rise, reflecting a growing preference for products that are free from products derived from genetically modified organisms (GMOs).
This trend highlights the increasing importance of offering organic products that are guaranteed to be free of GMOs. GMO, or genetically modified organism, refers to any organism whose genetic material has been altered using genetic engineering techniques. These white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application modifications involve introducing genes from one organism into another, often with the aim of LU10318% enhancing desirable traits such as resistance to pests or increased crop yields. However, + concerns have been raised regarding the potential long-term impacts of GMOs on human oo health and the environment. To cater to the growing demand for GMO-free products, it is ee essential to employ a composition that exclusively utilizes compounds derived from non- 2 © genetically modified organisms in both components according to claim 1 of this invention. = @
Organic products, in particular, are expected to be free from GMOs and their derivatives.
Organic farming practices prioritize the use of natural methods and avoid synthetic chemicals, S as well as products derived from genetically modified organisms. Organic certification standards mandate that products labeled as organic must adhere to stringent criteria, including being free from GMOs and GMO derivatives. The significance of this composition becomes evident when considering products derived from GMOs, such as asparaginase, which are not permitted in organic food production. Consequently, organic producers may encounter challenges in meeting the required thresholds for food-borne toxins without employing the composition disclosed in this invention.
Coatings may refer to any additional component used to separate the first and second component and provides the means to create a physical barrier between the two components and thus preventing a reaction between the two. An example for a coating is described in patent specification DE102019113073A1 to separate a carbonate salt from an acid component. This has the disadvantage that additional costs and steps are required during production, the composition is not active immediately but only after thermal activation, and it must be stored at low temperatures.
Advantageously, the composition in accordance with the current invention does not require any coating or separating agent, since the composition is stable after the blending process according to the method of preparation and can be stored under ambient conditions. This increased stability allows for reduced transportation and storage costs. In addition, the mixture is instantaneously effective and does not require any onset time due to the melting of the coating layer. Furthermore, this allows for treatment of a broader class of food-item.
Thermally processed food items refer to any food item which is heated, preferably between 80 and 400°C, during its preparation or production. Examples may include, but are not limited to, bakery and extruded products, such as breads, wafers, crackers, cookies, biscuits, breakfast cereals and rusks, vegetable-based, legume-based, nut-based, and fruit-based products, hot white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application and cold beverages and syrup-like substances including coffee, fruit juices, alcoholic LU10318% beverages, and honey. +
In a preferred embodiment, the first component comprising a salt comprising at least a C2-Ce a mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived anion. 2 ©
This has the technical advantage that shorter carboxylic acids (C+) can be decomposed either = ® thermally or acid-induced, e.g., to carbonate or formate salts, making them unsuitable for many > foods because the structure is destroyed, although gas evolution and CO formation can be a S ee production risk. In addition, salts derived from longer acids (>Ce) are usually more costly, non- ee polar or surfactant-like in behavior and therefore incompatible with many foods. The chosen carboxylic acids therefore have an economic advantage.
In a preferred embodiment of the current invention, the carboxylic derived acid anions (also referred to as anions) are natural occurring. These anions are usually biocompatible, which has several advantages. Furthermore, biocompatible anions from sustainable production are environmentally friendly and promote environmentally conscious food production. Finally, these anions, which are naturally derived and familiar to consumers, lead to greater acceptance and regulatory compliance.
In a preferred embodiment, the second component comprises a an organic C»-Cs carboxylic acid. An organic acid in the spirit of the present invention is a compound containing one or more carboxyl (COOH) functional groups and having the general chemical formula R-COOH, where R represents a hydrocarbon group. It exhibits acidic properties by releasing hydrogen ions (H*) in solution.
In a preferred embodiment of the current invention, an organic carboxylic acid in the spirit of the invention may be a Cz-Cs carboxylic acid corresponding to a C2-Ce carboxylic acid anion comprised by a salt comprised by the first component. Therefore, in some preferred embodiments, the first and second component may be derived from the same acid. This may have regulatory, procedural, cost and supplier advantages.
In an especially preferred embodiment, wherein the first and second component are derived from the same C,-Cg carboxylic acid the composition may be prepared by partial neutralization of C,-Cs carboxylic acid, either in concentrated form, preferably 90-99%, or in solution, preferably 10-90 wt% dissolved acid in a liquid, preferably water, by adding a metal or a basic metal salt, such as a metal hydroxide, metal hydride, metal carbonate and/or metal hydrogen carbonate. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
Advantageously, in some embodiments of the current invention, the composition may form a + buffered solution, thus stabilizing the pH value in a slightly acidic medium. This has the oo technical advantage that the pH is stable in a number of food-items, thus reducing the Te generation of base promoted food toxins. This is because salts of weak acids, as can be used 2 © as the first ingredient in the composition, can form an equilibrium in combination with weak = @ acids that can balance additional acids or bases within certain limits. For example, in baking applications, a slightly acidic buffered composition as additive can contribute to dough conditioning, affecting gluten development and enhancing the overall quality of baked goods. S
Furthermore, the use of a slightly acidic buffered additive in food-items offers enhanced flavor profiles, improved preservation, and effective emulsification and stabilization and thus may enhance the overall quality, taste, and safety of food products.
While cationic salts have been observed to elevate HMF levels in food, judicious selection of the cationic compound concentrations can be critical, as specifically, higher levels of monovalent cationic compounds haven't been shown to significantly escalate HMF levels.
Therefore, in an aspect of the current invention related to the employment of the second component compounds disclosed in this patent, it is possible to concurrently diminish HMF levels while maintaining or even reducing the presence of other foodborne toxins.
In an especially preferred embodiment, a blend of multiple compounds can be utilized to enhance the functionality or intended efficacy of the second component. The constituents of the second component and their mechanistic impact on food-borne toxin production pathways can further be leveraged to effectively diminish individual toxins or concurrently decrease multiple toxins simultaneously. It is a great achievement of the inventors to have found compositions, which are able to do so while employing comparatively safe and cost-effective salt and acid combinations, as disclosed herein.
In some embodiments of the invention, composition described in the invention provides a dry and free-flowing products that exhibit excellent stability without the need for additional ingredients such as coating agents, release agents or anti-caking agents.
The reduction in food toxin content refers to the reduction in thermally generated food toxin content by 10 to 100%, preferably by 12 to 95%, more preferably by 14 to 90%, compared to a comparable untreated food item. An untreated food item is any item prepared according to common method without the use of special additives and/or ingredients, especially those which modify amino acid composition or content, which aim to reduce the content of food toxins. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
“Reduces” does not refer to the actual chemical process of the composition according to the LU10318% current invention. +
Advantageously, in preferred embodiment the disclosed products can be effectively utilized in Te pre-mixes alongside a diverse range of other ingredients. As a result, the final product can be 2 © conveniently stored, transported, and seamlessly incorporated into various food products. The = @ dry and free-flowing nature of the product simplifies dosing and ensures precise measurements, allowing for easy integration into the desired food product. This characteristic S se enhances the versatility and practicality of the composition, providing food manufacturers and S intermediary additive suppliers with a practical solution for incorporating the product into their formulations while maintaining product integrity throughout storage, transportation, and usage.
In one preferred embodiment the salt comprises at least a C2-Ce mono- and/or di- and/or tri- valent carboxylic acid derived anion, preferably substituted with an alkyl, hydroxy, and sulfhydryl group, and/or oxyacid derived anion and at least a metal cation, preferably mono-, di- and/or tri-charged.
In one alternative embodiment, the first component consists of a cation chosen from sodium, potassium, calcium, or ferric salt of a C2-Ce monocarboxylic, dicarboxylic, or tricarboxylic acid preferably substituted with an alkyl, hydroxy, and sulfhydryl group or a mono-, di- or trivalent oxy acid salt.
The constituents of the first component and their mechanistic impact on food-borne toxin production pathways can be leveraged to effectively diminish individual toxins or concurrently decrease multiple toxins simultaneously. Multivalent cationic C2-Ce monocarboxylic, dicarboxylic, or tricarboxylic acid anions as well as multivalent cationic oxy acid anions can influence the kinetics of Maillard pathways, which have been demonstrated to consistently decrease acrylamide across a range of food products.
In some preferred embodiments monovalent oxy acid anions, particularly sodium sulfite, and divalent oxy acid anions such as calcium sulfate, have correlated strongly with reductions in furan formation in food. While cationic salts have been observed to elevate HMF levels in food, judicious selection of the cationic compound concentrations can be critical, as specifically, higher levels of monovalent cationic compounds haven't been shown to significantly escalate
HMF levels. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Therefore, it is a great achievement of the inventors to have found compositions in which LU10318% through careful employment of a combination of the first and second component disclosed in + this patent, it is possible to concurrently diminish HMF levels while maintaining or even oo reducing the presence of other foodborne toxins. Te £3
More preferably the first component is selected from the sodium, potassium, calcium, or ferric = @ salt of acetic acid, propanoic acid, lactic acid, citric acid, malic acid, and tartaric acid or from sodium, potassium, calcium or ferric phosphates, sodium, potassium, calcium, or ferric sulphate and sodium, potassium, or calcium sulfite. A blend of multiple compounds can be N utilized to enhance the functionality or intended efficacy of the first component.
In the spirit of the current invention, amino acids are not regarded as C»-Cs mono- and/or di- and/or tri-valent carboxylic acids and/or oxy acids being part of the first component, since the addition of amino acid salts, which are generally basic, would lower the acidity in solution (increase in pH value) of the composition.
High pH values are detrimental to the reduction of thermally formed food-toxins. Any composition with a pH value (10 wt% solution of the composition in water) between 0-7, more preferably between 1 and 6 is considered acidic in the spirit of the current invention.
The selection of counter cations of the first component of the invention in food additives is essential. Careful selection of biocompatible and abundant cations offers several technical advantages. First, they result in a lower health risk because they are generally recognized as safe (GRAS). Second, these cations exhibit lower toxicity, which contributes to a safer consumption experience. In addition, their efficient metabolism and elimination from the body result in minimal residue formation. Their better digestibility contributes to easier digestion and improved nutrient absorption.
In a particularly preferred embodiment, the salt comprises at least an anion selected from the group consisting of C2-Ce mono-, di-, tricarboxylates, phosphates, sulfates, sulfites and at least a metal cation selected from the group consisting of sodium (Na”), potassium (K*), calcium (Ca?*) ferric iron (Fe**), or a mixture thereof.
In an especially preferred embodiment, high valent cations, such as Ca?* or Fe**, are preferred.
These highly valent ions have been shown to be particularly useful in suppressing certain reaction pathways, with an outstanding achievement of the inventors being that in embodiments in which these ions are combined with certain anions of the first component and white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application acids of the second component, at least two of the three toxins acrylamide, furan, and HMF LU10318% are reduced simultaneously, which has not been possible previously because highly valent + ions can promote the formation of HMF, for example. oo
In a most preferred embodiment, the salt comprises at least an C2-Ce mono- and/or di- and/or #2 tri-valent carboxylic acid derived anion selected from the group consisting of acetate, = @ propanoate, lactate, citrate, malate and tartrate and a metal cation selected from the group consisting of sodium (Na*), potassium (K*), calcium (Ca?*) ferric iron (Fe**) or a mixture thereof. S se
This has the benefit that the aforementioned acids and its salts are food supplements with E S
Number in compliance with the EFSA and are exceptionally cost effective. This leads to an especially high economic advantage for compositions comprising acetic acid, propanoic acid, lactic acid, citric acid, malic acid and tartaric acid or a mixture thereof.
Preferably, the second component of the composition comprises a C,-Cs mono- and/or di- and/or tri-valent carboxylic acid preferably substituted with an alkyl, amino, hydroxy, and sulfhydryl group. It has been observed that the addition of C2-Ce monocarboxylic, dicarboxylic, or tricarboxylic acids, especially substituted with an alkyl and hydroxy group, effectively reduces the pH of food, leading to a substantial decrease in the formation of acrylamide and furan. This has the technical advantage of leading to a synergistic effect in conjunction with the first component in reducing the content of thermally formed food toxins.
In some examples, lowering the pH value has shown to increase the levels of HMF. Therefore, careful selection of the carboxylic acids is required to avoid promoting HMF formation. In a particularly preferred embodiment of the invention, it was found that the combination of the first and second components results in a buffered system that can inhibit low pH (strongly acidic conditions) and thus reduce HMF formation.
In some embodiments, the second component may include naturally occurring acids, such as natural carboxylic acids, fruit acids or amino acids. This has the advantage that the second component of the composition can be derived from natural sources, thus enabling compositions that are organic, which is a highly desirable consumer criterion. In addition, the second component is more biocompatible, environmentally friendly and less toxic.
In a more preferred embodiment the C,-C¢ mono- and/or di- and/or tri-valent carboxylic acid is selected from the group consisting of acetic acid, propanoic acid, lactic acid, citric acid, malic acid, tartaric acid, glycine, cysteine, leucine, and glutamic acid or a mixture thereof. These acids have been shown to be effective in reducing food toxins. These naturally occurring acids white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application are recognized food additives and/or generally safe for consumption (see Table 2) and are LU10318% therefore consumer friendly and can be used and sold in most markets, resulting in great + economic potential. oo
In a preferred aspect of the invention related to amino acids, the addition of glycine leucine fy ond and/or glutamic acid has shown to be able to reduce the levels of HMF in food-items. In a = @ preferred embodiment, a combination of these amino acids with a first component according to the present invention may be used to reduce simultaneously the content of acrylamide, HMF S se and furan. This is unprecedented in the state of the art and is a great improvement, allowing S to reduce health hazards of these substances associated with increased cancer risk, genotoxicity and oxidative stress. Since decreasing the pH value may increase the level of
HMF, addition of these acids as a second component counteracts this effect thus leading to a broad response of reducing HMF without increasing the other toxins.
Some economically viable and readily available options for reducing the pH of food products include acetic acid, propanoic acid, lactic acid, citric acid, malic acid, and tartaric acid. These acids are generally considered safe for consumption (see Table 2), ensuring compliance with legal food safety standards, which simplifies labeling and increases consumer confidence.
Standardized use of recognized numbers also facilitates international trade by making it easier to demonstrate compliance with specific additive regulations in different markets. Furthermore, these acids are cost effective and easily available, leading to a great economic potential of the composition, especially in comparison with existing alternatives.
In a preferred embodiment, the composition relates to the reduction of food-borne toxins, preferably thermally formed food toxins, particularly preferably the food toxins acrylamide, furan and hydroxymethylfurfural. These substances are formed particularly when foods are heated and represent a major contributor to the toxicity and health risks associated with these foods. Acrylamide, formed when starchy foods are cooked at high temperatures, is a probable human carcinogen associated with an increased risk of cancer, particularly in the kidneys and uterus. Furan, a volatile compound formed when foods are processed at high temperatures, is a possible carcinogen and may increase the risk of liver and gastrointestinal cancers.
Hydroxymethylfurfural (HMF), which is formed in certain sugary foods when heated, may have adverse health effects related to genotoxicity and oxidative stress.
Therefore, reducing acrylamide, furan, and HMF in foods lowers cancer risk, increases food safety, and helps meet regulatory requirements. Lower levels of these compounds lead to white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application improved food quality and longer shelf life. Consumer confidence is boosted by efforts to LU10318% minimize harmful substances in food, so consumers can make healthier choices. +
Preferably, the composition can reduce the content of preferably at least one, more preferably Te atleast two of the food-toxins selected from acrylamide, furan and hydroxymethylfurfural, while 2 © the formation of the other food-toxins is preferably simultaneously not promoted. = @
This is possible since it has been demonstrated that the addition of C2-Ce monocarboxylic or dicarboxylic acids containing amino and sulfhydryl groups, such as glycine or cysteine, has S shown the ability to simultaneously lower HMF and acrylamide levels. Especially acids with specific functional groups can offer a promising approach to mitigate the formation of undesirable compounds in food.
It is therefore a difficult task to find a combination of components that suppress both the formation of acrylamide by a Maillard reaction and the formation of furan and HMF. For example, the literature showed that highly valent metal cations suppress the Maillard reaction while simultaneously increasing the formation of HMF. It is therefore an outstanding achievement of the inventors to have found compositions in which synergistic effects lead to a reduction of all three food toxins mentioned above. In particular, the careful selection of the components play an important role. In some embodiments of the current invention, due to the unique combination of high valent cations and controlled acidic conditions, a number of different food-toxins may be reduced simultaneously.
A deliberate and well-considered selection of the first and second components can synergistically facilitate the reduction of one or multiple food-borne toxins, even in cases where they exhibit antagonistic behavior. By simultaneously targeting the formation of food-borne toxins through multiple reaction pathways, not only can an effective reduction be achieved, but also a consistent and robust reduction with minimal variation in results.
Thus, itis an outstanding achievement of the inventors to have found combinations of salt and acid that simultaneously reduce the levels of various food toxins produced during thermal treatment of foods via different reaction pathways, and even to have achieved particularly preferred embodiments in which the combination exhibited unprecedented synergistic effects.
These compositions reduce the individual food toxins in a greater amount than the individual components, resulting in a more effective reduction of the overall toxicity of the food, which is very beneficial for consumer health. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
In an especially preferred embodiment of the current invention, the inventors have found a LU10318% combination of calcium citrate as an embodiment of the disclosed first component and acetic + acid as an embodiment of the disclosed second component demonstrates synergistic effects, oo effectively reducing acrylamide in bakery products by 80 % (Example 7 and Figure 3). Te £3
Further, in an aspect of the invention related to a mixture of potassium acetate and calcium = @ sulfite as embodiments of the disclosed first component in combination with citric acid as an embodiment of the disclosed second component reduces acrylamide by 43% (Example 2 and S se
Figure 1) and furan by 26% (Example 3 and Figure 1) in dark roasted coffee. Similarly, the S beforementioned mixture as an embodiment of the composition disclosed in this patent reduces acrylamide by 14% (Example 4 and Figure 1) and furan by 63% (Example 5 and
Figure 1) in medium roasted coffee. These findings provide compelling evidence that the approach is not only effective in reducing individual food-borne toxins but also capable of simultaneously eliminating multiple food-borne toxins, significantly enhancing food safety overall and enabling compliance to regulatory requirements, as binding thresholds can be met.
The selection of compounds within the components, the optimal ratios between different compounds within the components, and the ratios of the components to each other depend on various factors, including: 1. The physiochemical characteristics of the individual compounds (pKa, solubility, thermal stability, functional groups, etc.). 2. The specific food product to which the components are intended to be added. 3. The way of addition to the final food product (topical addition, incorporation, soaking, etc.). 4. The physiochemical condition and recipe of the food product. 5. The processing conditions involved in the production of the food product. 6. The regulatory requirements concerning the compounds used in the food product. 7. The specific type or types of food-borne toxins that need to be reduced. 8. The cost considerations associated with the individual compounds.
For instance, it has been shown, that a combination out of calcium acetate as an embodiment of the disclosed first component and acetic acid as an embodiment of the disclosed second component can effectively reduce acrylamide in bakery products. The optimal dosage range for this combination is found to be 0.7 to 1.4 bakers-%, where higher dosages lead to greater reductions in acrylamide content (Example 6 and Figure 2). Similarly, a comparable dosing white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application level of 0.7 to 1.4 bakers-% can be applied to achieve effective results regarding the reduction LU1 03188 of acrylamide in other types of bakery products (Example 7 and Figure 3). +
In this context, "bakers-%" refers to a dosage expressed as a percentage relative to the Te weight of flour used in the bakery product. 2 ©
In some aspects of the current invention the composition can reduce food-borne toxins, > especially acrylamide, furan and hydroxymethylfurfural, preferably by 10 to 100%, more S se preferably between 12 and 95%, most preferably between 14 and 90% in comparison with the S untreated food-items. This solves many of the associated health risks and minimizes consumer exposition, therefore leading to a healthier food item.
In a preferred embodiment, the mass fraction of the second component is preferably between 5 and 40%, more preferably between 10 and 35% of the total weight of the composition.
In a more preferred embodiment regarding an acidic composition, the mass ratio of the second component to the first component is in the range of between 1:19 and 2:3, more preferably between 1:9 and 7:13. The acid component plays an important role in reducing many reaction pathways leading to food toxins, as described herein. The inventors have determined that in addition to the selection of substances for the first and second compounds, a carefully balanced composition of the first and second compositions is also required. This allows for the high reduction and multitasking capability of the composition, which can preferably target a number of different toxins simultaneously.
In a preferred embodiment of the current invention all the components of the composition, especially preferably the first and second component, are approved food additives and/or
GRAS substances, more preferably food additives with an E number as approved by the
European Food Safety Authority (EFSA) and/or food additives with FEMA number by the Food and Drug Administration (FDA). This has the technical effect that a composition containing components with assigned E numbers or FEMA numbers ensures regulatory compliance with food safety standards, therefore simplifying labeling and enhancing consumer confidence. The standardized use of recognized numbers also facilitates international trade, making it easier to demonstrate compliance with specific additive regulations in different markets.
Further, while these compounds have received regulatory approval for use in food across major markets, including the European Union and the United States, many of these compounds are even permitted according to organic regulations in these markets, further white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application enhancing their suitability for organic food production. This combination of availability, cost- LU10318% effectiveness, non-GMO status, and regulatory compliance makes the compounds highly + advantageous for use in the disclosed composition, providing manufacturers and producers os with a reliable and compliant solution for achieving food safety and quality goals. Te £3
In an especially preferred embodiment, the composition is chosen from the first component = @ chosen from Table 1 and the second component chosen from Table 2 or mixtures thereof.
Each combination is a new embodiment of the current invention and an aspect thereof. ° Se = Ss
Table 1. E and FEMA Numbers of the first component of the current invention
Salt (first component) E Number FEMA Number “Sodium acetate ~~ E262 oo
Sodium diacetate E262ii -
Potassium acetate E261 -
Calcium acetate E263 -
Sodium propionate E281 -
Calcium propionate E282 -
Sodium lactate E325 -
Potassium lactate E326 -
Calcium lactate E327 -
Trisodium citrate E331 -
Monosodium citrate - FEMA 3025
Disodium citrate - FEMA 3026
Tripotassium citrate E332 -
Monopotassium citrate - FEMA 3024
Dipotassium citrate - FEMA 3023
Calcium citrate (2:3) E333 -
Ferric citrate - FEMA 3288
Malic Acid E296 -
Sodium malate - FEMA 2709
Potassium malate - FEMA 2710
Calcium malate - FEMA 2711
Ferric malate - FEMA 2712
Tartaric Acid E334 -
Sodium tartrate E335 -
Potassium tartrate E336 - white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Salt (first component) E Number FEMA Number LUTOS18R
Ferric tartrate - FEMA 3676 oR
Table 2. E and FEMA Numbers of the second component of the current invention 3 &&
Acid (second component) E Number FEMA Number “S ‘AceticAid« ss E280 - S 5
Propanoic Acid E280 -
Lactic Acid E270 -
Citric Acid E330 -
Malic Acid E296 -
Tartaric Acid E334 -
Glycine - FEMA 3287
Cysteine E920 -
Leucine - FEMA 3782
Glutamic Acid - FEMA 3285
Furthermore, a liquid composition for treatment of non-powdered food items, preferably such as coffee, potato products, nuts, or legumes comprising a composition according to the current invention, wherein the liquid composition comprises the composition in a liquid in a range of 5 to 80 wt%, more preferably in a range of 10 to 60 wt% of the total weight of the liquid composition.
In certain applications like coffee, potato products, nuts, or legumes, where topical addition or incorporation of additives is not feasible due to the nature or desired characteristics of the final product, soaking the food product in an additive solution becomes necessary. Since the absorption rate of the solution is significantly influenced by factors such as the nature of the food, its penetrability, and environmental conditions like pH, temperature, and the type of solvent used, only a limited amount of the solute can effectively permeate the final food product. As a result, in a preferred embodiment a higher dosage is necessary when compared to a scenario involving topical addition or incorporation.
In one especially preferred embodiment, a mixture of potassium acetate and calcium sulfite as embodiments of the disclosed first component in combination with citric acid as an embodiment of the disclosed second component (Example 2 and Example 3) was formulated in a 15% w.w. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application solution with water to facilitate the absorption of the solute by green coffee beans prior to LU10318% thermal processing, enabling the disclosed product of the invention to effectively showcase its + ability to reduce food-borne toxins. The solubility of the individual compounds within the oo additive mixture holds significant importance in this approach. Te £3
Since there may be remaining unabsorbed solute in the solution after the soaking process, it = ® becomes possible to reuse the solution for subsequent soaking batches. This recycling of the > solution ensures that the process remains economically viable, as it minimizes wastage and allows for efficient utilization of the solute. S
This specification discloses an effective method for preparing the composition according to the current invention, wherein a. afirst component, preferably a mono-, di- and/or trivalent carboxylic or oxy acid salt, individually or as a mixture is provided and then b. a second component, preferably a C2-Ce monocarboxylic, dicarboxylic, or tricarboxylic acid preferably substituted with an alkyl, amino, hydroxy, and sulfhydryl group, individually or as a mixture is added, then c. the first and second components and preferably additional components are blended at room temperature.
This invention employs a simple and cost-effective manufacturing process, requiring no additives or catalysts for large-scale production of the disclosed food-borne toxin reducing products. The blending of the individual components allows for easy application of the compound and ensures the use of the correct ratios and mixing of the first and second components used and thus the desired reduction of toxins.
For the use of solid compounds at room temperature and standard pressure as part of the second component of the invention, a blending process can be utilized. This is especially applicable for compounds as part of the second component of the invention such as citric acid, malic acid, tartaric acid, glycine, cysteine, leucine, and glutamic acid. To create a homogeneous mixture, all compounds from the first component and the second component as per the invention are accurately weighed and introduced into a blender or mixing vessel, whereafter the blending process continues until a uniform mixture is obtained. This blending process, even on a large industrial scale, can typically be completed within 10 to 20 minutes.
Once complete, the mixture is discharged and carefully packaged in food-grade bags or containers appropriate for the intended usage. The size and material of the packaging are white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application selected based on the specific requirements of the product, ensuring the preservation of quality LU1 03188 and safety during storage and transportation. +
For the use of liquid compounds at room temperature and standard pressure as part of the Te second component of the invention, a process proposed in patent document 2 ©
WO002022258807A1 can be utilized. = @
This is especially applicable for compounds as part of the second component of the invention S Se gy Wx such as acetic acid, propanoic acid and lactic acid. To create a homogeneous mixture, all ve compounds from the first component and the second component as per the invention are accurately weighed, whereafter the compounds of the first and second component as per the invention which are of solid nature are introduced into a blender or mixing vessel. Hereafter, the compounds of the second component as per the invention which are of liquid nature are slowly dosed into the mixing vessel and sprayed onto the solid components under agitation, leading to the adsorption of the liquid components onto the solid components.
This process, on a large industrial scale, can typically be completed within 30 to 120 minutes, pending type of solid and liquid compounds used. Once complete, the mixture is discharged and carefully packaged in food-grade bags or containers appropriate for the intended usage.
The size and material of the packaging are selected based on the specific requirements of the product, ensuring the preservation of quality and safety during storage and transportation.
This specification discloses a method for preparing thermally treated food items having reduced levels of food-borne toxins is disclosed, wherein the food-item is treated with a composition, either by mixing and/or by soaking the food items in a solution of the composition prior to thermal treatment, preferably but not limited to heating, boiling, frying and/or roasting.
Due to the toxin reducing properties of the composition as disclosed herein, the processed foot items have a reduced contend of health risk affiliated toxins, while also utilizing components which are generally safe for consumption. The composition additionally is instantaneous effective, not requiring activation by heat as some coated solutions of the prior art or require time to enzymatically reduce the contend of parent compounds for the thermally generated food toxins. This has the advantage that the composition can be quickly adapted into existing procedures for industrial or private production of thermally threaded food-items, thus allowing for easy and cost-effective application. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
In one alternative embodiment, the invention discloses a Kit providing an acidic composition LU10318% according to the current invention, wherein the kit comprises at least a first container providing + a first component comprising a at least a salt that comprises at least an anion, preferably a Cz- oo
Ce mono- and/or di- and/or tri-valent carboxylic acid derived anion and/or oxyacid derived Te anion, and at least a metal cation according to this disclosure and a second container providing 2 © a second component comprising an acid, preferably an organic C2-Ce carboxylic acid, to this = = disclosure, wherein the composition provided by the kit is leavening agent-, GMO- and coating- free and reduces food-borne toxins present and/or produced during thermal processing of food-items when applied. This has the technical advantage that the kits can be adapted to S different applications and the components may be added at different steps of the food item preparation process, having potential implications in the texture, taste, and processing time, thus allowing for a broader and customized application.
In one embodiment, the kit comprises a first container providing only a first component and a second container providing only a second component. In a preferred embodiment, the first container provides at least one first component, and the second container provides at least one second component.
Due to the multifactorial dependencies of types, ratios, and dosing rates, it is only possible to establish ratios on a case-by-case basis. However, for product groups like bakery items and specific food-borne toxins such as acrylamide, dosing rates with predetermined optimal ratios can be generalized for individual products.
One aspect discloses the use of a composition, and/or a kit according to the current invention, in which a composition and/or a kit is brought into solution in order to be absorbed by food prior to thermal processing.
The use of the disclosed composition offers an effective and robust solution for reducing multiple food-borne toxins. By utilizing the specific compounds outlined in the invention, the composition successfully addresses the presence of these toxins in food products and enables manufacturers and producers to confidently enhance the safety and integrity of their food products by individually or simultaneously addressing multiple food-borne toxins, aiding compliance with rigorous standards and regulations while safeguarding consumer well-being.
In one preferred embodiment a composition and/or a kit according to the current invention is used in bakery and extruded products including breads, wafers, crackers, cookies, biscuits, breakfast cereals and rusks. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
In one additional embodiment a composition and/or a kit according to the current invention is + used in vegetable-based, legume-based, nut-based, and fruit-based products including oo potatoes and olives. © =
In an especially preferred embodiment, a composition and/or a kit according to the current = @ invention is used in hot and cold beverages and syrup-like substances including coffee, fruit juices, alcoholic beverages, and honey. S Se = Ss
The decision of which composition to use in a food product depends on many factors, as does the appropriate dosage of the final product according to the present invention, including but not limited to: 1. The sensory impact that the product has on taste, olfactory, and visual aspects of the food. 2. The desired reduction in food-borne toxins to meet regulatory or industry-established thresholds. 3. The economic feasibility, considering the balance between benefits and costs.
The disclosed composition offers broad applicability for the products of the invention to be utilized across a wide range of food products. These products can be effectively incorporated into various thermally processed food items that are susceptible to the development of food- borne toxins. The applications of the products of the invention extend to but are not limited to: 1. Bakery and extruded products: This includes a diverse range of items such as breads, wafers, crackers, cookies, biscuits, breakfast cereals, and rusks. 2. Vegetable-based, legume-based, nut-based, and fruit-based products: These encompass a variety of products, including items such as potatoes, nuts, beans and olives. 3. Hot and cold beverages and syrup-like substances: This category covers a broad spectrum of beverages, including coffee, fruit juices, alcoholic beverages, and honey.
The products of the invention can be effectively employed in conventional food groups, as well as those with specific restrictions related to their GMO-free nature, such as organic products.
Their purpose is to individually or simultaneously reduce food-borne toxins, providing a reliable solution for enhancing food safety and quality in a wide array of organic and conventional foods. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
The disclosed composition further offers a cost-effective and straightforward implementation LU10318% of the products of the invention. It requires limited to no process adaptations, such as special + storage and transport conditions, which minimizes additional costs and complexities for oo customers in the food industry. Moreover, there is limited to no investments needed in Te machinery or peripheral equipment, resulting in savings in implementation expenses and time. 2 ©
In contrast to alternative solutions, such as enzyme-based approaches, the composition or kit = @ does not require pretreatment time, eliminating delays associated with longer stand times and allowing for higher throughputs, thereby enhancing the economic viability of the disclosed “Re products. The composition and/or kit offers an efficient and streamlined process for ve incorporating the products into existing production lines, without compromising productivity or efficiency. Additionally, the compounds used in the invention have obtained regulatory approval in all major markets. This regulatory compliance ensures there are no significant regulatory hurdles or red tape to navigate when immediately implementing the products, wherefore manufacturers and producers can confidently utilize the products without facing unnecessary regulatory delays or complications. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
EXAMPLES LU103 18%
The present invention is further described and illustrated in the following comparatives, = experiments, drawings, and examples, which are not intended to limit the scope of the 2 invention in any manner. 2 S
Herein shows 29 y Site
N Na
Fig. 1: Effect of a disclosed compound solution on the acrylamide and furan formation in = S medium and dark roasted coffee
Fig. 2: Effect of a disclosed compound on acrylamide formation in gingerbread
Fig. 3: Effect of a disclosed compound on acrylamide formation in crispbread
The foregoing are only some preferred and practicable embodiments of the present invention.
Therefore, any equivalent structural changes made by application of the description of the invention are to be included within the scope of the patent application.
Although the invention has been described and illustrated with reference to specific embodiments, the invention is not intended to be limited to those embodiments. Those skilled in the art will recognize that variations and modifications may be made without departing from the true scope of the invention as defined by the claims and description. It is therefore intended to include within the scope of the invention all variations and modifications which fall within the scope of the appended claims and their equivalents. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
Example 1 — Preparation of Disclosed Compounds ®
The preparation process of three compounds according to the invention is outlined in this — example. The composition of these three formulations can be found in Table 3. © S
IN
Table 3. Composition of Disclosed Compounds 3 Ne
SN
Formulation Nr. Component Composition Formular % ww. SD
Sec. Component Citric Acid CeHsO7 33.33 1 First Component Sodium Sulfite Na:SO3 33.33
First Component Potassium Acetate C2H3KO2 33.33
TU A A Cac hese Cicao Ter 2
Sec. Component Glacial Acetic Acid CH;COOH 33 ~~ FirstComponent Calcium Citrate Cas(CeHsOr)2 77 3
Sec. Component Glacial Acetic Acid CH;COOH 23
To prepare Formulation 1, the three components (citric acid, sodium sulfite, and potassium acetate) were thoroughly combined to achieve a uniform mixture. When considering
Formulations 2 and 3, glacial acetic acid, a liquid compound, was progressively incorporated into the solid compound calcium acetate or calcium citrate. This addition was performed while continuously stirring the mixture until a dry, homogenized formulation was achieved.
Example 2 — Acrylamide Reduction in Dark Roasted Coffee
The effect of a disclosed compound on acrylamide formation in coffee is outlined in this example. Formulation 1 from Example 1 was used in this example. The reduction potential of acrylamide was investigated in dark roasted coffee. The quantification of acrylamide content was carried out using High-Performance Liquid Chromatography coupled with Tandem Mass
Spectrometry (HPLC-MS/MS).
The dark roasted coffee was prepared by roasting 80g of green Arabica coffee beans at 240°C for 8 minutes and 30 seconds. Notably, the first crack occurred around the 3-minute-40-second mark, and the second crack appeared at approximately 6-minute-40-seconds. The control sample of dark roasted coffee revealed an acrylamide concentration of 122 ppb. In order to test the efficacy of Formulation 1 on acrylamide formation in dark roasted coffee, 80g of green
Arabica coffee beans were first soaked in a 100g solution containing 15% w.w. Formulation 1 white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application for 5 hours and then dried out at 80°C for 1:30 hours and then at 100°C for another 35 minutes. LU10318%
LH
Thereafter the beans were roasted at 240°C for 8 minutes and 30 seconds. Notably, the first Ss crack occurred around the 4-minute-40-second mark, and the second crack appeared at = approximately 7-minute-40-seconds. The treated sample of dark roasted coffee revealed an © NN
Von acrylamide concentration of 69 ppb. In terms of taste, olfactory, and visual characteristics, fy ond there was minimal divergence between the control and the treated sample, however, the = S
Nd treated sample exhibited a lighter hue. Moreover, a diminished release of chaff was observed y Dw during the roasting of the treated sample, largely due to the majority of the chaff having already S = been discharged during the soaking process. The results of the acrylamide test can be found ve in Table 4 and Figure 1.
Table 4. Effect of Disclosed Compounds on Acrylamide Formation in Dark Roasted Coffee
Food-borne Toxin Coffee Roast Blank (ppb) Formulation 1 (ppb) Reduction
Acrylamide Dark 122 69 43%
The results indicate that Formulation 1 as an example of a disclosed compound according to the invention was able to effectively reduce acrylamide in coffee dark roasted coffee.
Example 3 —Furan Reduction in Dark Roasted Coffee
The effect of a disclosed compound on furan formation in coffee is outlined in this example.
Formulation 1 from Example 1 was used in this example. The reduction potential of furan was investigated in dark roasted coffee. The quantification of furan was determined using a
Headspace technique.
The dark roasted coffee was prepared by roasting 80g of green Arabica coffee beans at 240°C for 8 minutes and 30 seconds. Notably, the first crack occurred around the 3-minute-40-second mark, and the second crack appeared at approximately 6-minute-40-seconds. The control sample of dark roasted coffee revealed a furan concentration of 2300 ppb. In order to test the efficacy of Formulation 1 on furan formation in dark roasted coffee, 80g of green Arabica coffee beans were first soaked in a 100g solution containing 15% w.w. Formulation 1 for 5 hours and the dried out at 80°C 1:30 hours and then at 100°C for another 35 minutes. Thereafter the beans were roasted at 240°C for 8 minutes and 30 seconds. Notably, the first crack occurred around the 4-minute-40-second mark, and the second crack appeared at approximately 7- minute-40-seconds. The treated sample of dark roasted coffee revealed a furan concentration of 1700 ppb. In terms of taste, olfactory, and visual characteristics, there was minimal divergence between the control and the treated samples, however, the treated sample white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application exhibited a lighter hue. Moreover, a diminished release of chaff was observed during the LU10318% roasting of the treated sample, largely due to the majority of the chaff having already been + discharged during the soaking process. The results of the acrylamide test can be found in oo
Table 5 and Figure 1. © =
Table 5. Effect of Disclosed Compounds on Furan Formation in Dark Roasted Coffee = @
Food-borne Toxin Coffee Roast Blank (ppb) Formulation 1 (ppb) Reduction dx
Furan Dark 2300 1700 26% “ay
The results indicate that Formulation 1 as an example of a disclosed compound according to the invention was able to effectively reduce furan in dark roasted coffee.
Example 4 — Acrylamide Reduction in Medium Roasted Coffee
The effect of a disclosed compound on acrylamide formation in coffee is outlined in this example. Formulation 1 from Example 1 was used in this example. The reduction potential of acrylamide was investigated in medium roasted coffee. The quantification of acrylamide content was carried out using High-Performance Liquid Chromatography coupled with Tandem
Mass Spectrometry (HPLC-MS/MS).
The medium roasted coffee was prepared by roasting 80g of green Arabica coffee beans at 240°C for 5 minutes. Notably, the first crack occurred around the 3-minute-40-second mark.
The control sample of medium roasted coffee revealed an acrylamide concentration of 130 ppb. In order to test the efficacy of Formulation 1 on acrylamide and furan formation in medium roasted coffee, 80g of green Arabica coffee beans were first soaked in a 100g solution containing 15% w.w. Formulation 1 for 6 hours and the dried out at 80°C 1:30 hours and then at 100°C for another 35 minutes. Thereafter the beans were roasted at 240°C for 5 minutes.
Notably, the first crack occurred around the 3-minute-40-second mark. The treated sample of medium roasted coffee revealed an acrylamide concentration of 112 ppb. In terms of taste, olfactory, and visual characteristics, there was minimal divergence between the control and the treated samples. However, a diminished release of chaff was observed during the roasting of the treated sample, largely due to the majority of the chaff having already been discharged during the soaking process. The results of the acrylamide test can be found in Table 6 and
Figure 1. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Table 6. Effect of Disclosed Compounds on Acrylamide and Furan Formation in Coffee LU103 18%
Food-borne Toxin Coffee Roast Blank (ppb) Formulation 1 (ppb) Reduction =
Acrylamide Medium 130 112 14% 2 -_— D «
The results indicate that Formulation 1 as an example of a disclosed compound according to = N the invention was able to effectively reduce acrylamide in medium roasted coffee. >
SN
De
Example 5 — Furan Reduction in Medium Roasted Coffee “
The effect of a disclosed compound on furan formation in coffee is outlined in this example.
Formulation 1 from Example 1 was used in this example. The reduction potential of furan was investigated in medium roasted coffee. The quantification of furan was determined using a
Headspace technique.
The medium roasted coffee was prepared by roasting 80g of green Arabica coffee beans at 240°C for 5 minutes. Notably, the first crack occurred around the 3-minute-40-second mark.
The control sample of medium roasted coffee revealed a furan concentration of 2700 ppb. In order to test the efficacy of Formulation 1 on furan formation in medium roasted coffee, 80g of green Arabica coffee beans were first soaked in a 100g solution containing 15% w.w.
Formulation 1 for 6 hours and the dried out at 80°C 1:30 hours and then at 100°C for another 35 minutes. Thereafter the beans were roasted at 240°C for 5 minutes. Notably, the first crack occurred around the 3-minute-40-second mark. The treated sample of medium roasted coffee revealed a furan concentration of 1000 ppb. In terms of taste, olfactory, and visual characteristics, there was minimal divergence between the control and the treated samples.
However, a diminished release of chaff was observed during the roasting of the treated sample, largely due to the majority of the chaff having already been discharged during the soaking process. The results of the acrylamide test can be found in Table 7 and Figure 1.
Table 7. Effect of Disclosed Compounds on Acrylamide and Furan Formation in Coffee
Food-borne Toxin Coffee Roast Blank (ppb) Formulation 1 (ppb) Reduction
Furan Medium 2700 1000 63%
The results indicate that Formulation 1 as an example of a disclosed compound according to the invention was able to effectively reduce furan in medium roasted coffee. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Example 6 — Acrylamide Reduction in Gingerbread LUT03 18
AS
The effect of a disclosed compound on acrylamide formation in gingerbread is outlined in this = example. Formulation 2 from Example 1 was used in this example. The quantification of 2 acrylamide content was carried out using High-Performance Liquid Chromatography coupled 2 5 with Tandem Mass Spectrometry (HPLC-MS/MS). The recipe for the gingerbread can be found i nN in Table 8 and the results of the acrylamide tests can be found in Table 9 and Figure 2. 3 &
Table 8. Gingerbread Recipe SD
Ingredient Weight (g) Bakers-%
Flour Type 405 200.00 100.0%
Powdered sugar 66.66 33.3%
Molasses 50.00 25.0%
Butter 41.12 20.6%
Ammonium bicarbonate 0.56 0.3%
Baking soda 1.66 0.8%
Salt 1.66 0.8%
Water 24.00 12.0%
Cinnamon powder 0.83 0.4%
Ginger powder 0.42 0.2%
Clove powder 0.42 0.2%
Additive (Formulation 2) 0.007 1407280 60% 07% 14%
The given recipe was chosen to test the disclosed compounds in a challenging environment, as ingredients such as cinnamon and ammonium bicarbonate are known to yield high acrylamide levels. The Gingerbread samples were prepared by amalgamating sugar and fat until achieving a homogenous texture and subsequently integrating all constituents excluding flour, leavening agents, and any additional additives. Upon thorough blending, the remaining components were introduced, whereafter the dough was refrigerated. For the baking phase, the oven was set to a standard heat of 180°C, utilizing both upper and lower heating elements.
A two-stage baking procedure was implemented to ensure maximal acrylamide development.
Initially the doughs were baked for 9 minutes and 30 seconds, followed by a cooling interlude, then a secondary baking phase for 5 minutes.
Table 9. Effect of Disclosed Compound on Acrylamide Formation in Gingerbread white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Additive Dosing Acrylamide (ppb) Reduction LU109188 0.7 bakers-% 744 12% a% 1.4 bakers-% 618 27% 2 S
The results indicate that Formulation 2 as an example of a disclosed compound according to ne the invention was able to effectively reduce acrylamide in gingerbreads at low concentrations. % N ~ A
Example 7 — Acrylamide Reduction in Crispbread
The effect of a disclosed compound on acrylamide formation in crispbread is outlined in this example. Formulation 3 from Example 1 was used in this example. The quantification of acrylamide content was carried out using High-Performance Liquid Chromatography coupled with Tandem Mass Spectrometry (HPLC-MS/MS). The recipe for the crispbread can be found in Table 10 and the results of the acrylamide tests can be found in Table 11 and Figure 3.
Table 10. Crispbread Recipe
Ingredient Weight (g) Bakers-% ‘Ryefour ~~ 100.00 333% —
Wheat flour 100.00 33.3%
Whole wheat flour 50.00 16.7%
Whole grain rye flour 50.00 16.7%
Sunflower seeds 50.00 16.7%
Sesame seeds 50.00 16.7%
Ground fennel 2.00 0.7%
Butter 70.00 23.3%
Water 350.00 116.7%
Baking powder 4.00 1.3%
Sugar 2.00 0.7%
TS aa
Additive (Formulation 3) 0.00/3.00 0.0% /1.0% white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
The crispbread samples were prepared by initially preheating the oven to 160°C. The different LU10318%
ÈS types of flour, seeds, baking powder, salt, sugar, and fennel powder were combined. À well S was created for the softened butter and water, mixed and kneaded into an elastic dough, and oo then left to rest in a cool place for 30 minutes. The dough was subsequently rolled out and © NN
Von baked for 15 minutes, after which it was divided into specified sample sizes and baked for an fy ond additional 30 minutes. = N
Nd
Table 11. Effect of Disclosed Compound on Acrylamide Formation in Crispbread "nn
Additive Dosing Acrylamide (ppb) Reduction 0 baker-% 380 - 1.0 bakers-% 77 80%
The results indicate that Formulation 3 as an example of a disclosed compound according to the invention was able to effectively reduce acrylamide in crispbreads at low concentrations. white ip | Patent & Legal
BRAL-0008-P-LU 07.08.2023 LU Patent Application
Claims (19)
1. An acidic composition, preferably a food additive acidic composition, as additive in $ thermally processed food items, employing an at least dual-component mixture, oR comprising © = i. a first component comprising at least a salt that comprises at least an anion, 2 N° preferably a C2-Ce mono- and/or di- and/or tri-valent carboxylic acid derived x anion and/or oxyacid derived anion, and at least a metal cation, De ii. — a second component comprising at least one acid, preferably an organic C2-Ce ~ carboxylic acid, characterized in that the composition is leavening agent-, GMO- and coating-free and reduces food-borne toxins produced during thermal processing, preferably in a temperature range between 80 and 400°C, of food-items when applied.
2. The composition according to claim 1, wherein the salt comprises at least a C2-Ce mono- and/or di- and/or tri-valent carboxylic acid derived anion, preferably substituted with an alkyl, hydroxy, and sulfhydryl group, and/or oxyacid derived anion and at least a metal cation, preferably mono-, di- and/or tri-charged, or a mixture thereof.
3. The composition according to claim 2, wherein the salt comprises at least an anion selected from the group consisting of C2-Cs mono-, di-, tricarboxylates, phosphates, sulfates, sulfites; and at least a metal cation selected from the group consisting of sodium (Na*), potassium (K*), calcium (Ca?*) ferric iron (Fe**), or a mixture thereof.
4. The composition according to claims 2 and 3, wherein the salt comprises at least an C2-Ce Mono- and/or di- and/or tri-valent carboxylic acid derived anion selected from the group consisting of acetate, propanoate, lactate, citrate, malate and tartrate; and a metal cation selected from the group consisting of sodium (Na*), potassium (K*), calcium (Ca?*) ferric iron (Fe**) or a mixture thereof.
5. The composition according to claim 1, wherein the C,-C¢ mono- and/or di- and/or tri- valent carboxylic acid is preferably substituted with an alkyl, amino, hydroxy, and sulfhydryl group. white ip | Patent & Legal BRAL-0008-P-LU 07.08.2023 LU Patent Application
6. The composition according to claim 5, wherein the C2-Cs mono- and/or di- and/or tri- LU10318% valent carboxylic acid is selected from the group consisting of acetic acid, propanoic + acid, lactic acid, citric acid, malic acid, tartaric acid, glycine, cysteine, leucine, and os glutamic acid or a mixture thereof. Te £3
7. The composition according to any claims 1 to 6, wherein the reduction in food-borne = @ toxins preferably refers to thermally formed food toxins, especially preferably the food- toxins acrylamide, furan and hydroxymethylfurfural. S 3
8. The composition according to any claims 1 to 7, wherein the content of preferably at least one, more preferably at least two of the food-toxins selected from acrylamide, furan and hydroxymethylfurfural is reduced, while the formation of the other food-toxins is preferably simultaneously not promoted.
9. The composition according to any claims 1 to 8, wherein food-borne toxins, especially acrylamide, furan and hydroxymethylfurfural, are reduced preferably by 10 to 100%, more preferably between 12 and 95%, most preferably between 14 and 90% in comparison with the untreated food-items, measured by HPLC-MS/MS.
10. The composition according to claims 1 to 9, wherein the mass ratio of the second component to the first component is in the range of between 1:19 and 2:3, more preferably between 1:9 and 7:13.
11. The composition according to any claims 1 to 10, wherein all the components of the composition, especially preferably the first and second component, are approved food additives and/or GRAS substances, more preferably food additives with an E number as approved by the European Food Safety Authority (EFSA) and/or food additives with FEMA number by the Food and Drug Administration (FDA).
12. A liquid composition for treatment of non-powdered food items, preferably such as coffee, potato products, nuts, or legumes, comprising a composition according to any claims 1 to 11, wherein the liquid composition comprises the composition in a liquid in a range of 5 to 80 wt%, more preferably in a range of 10 to 60 wt% of the total weight of the liquid composition. white ip | Patent & Legal BRAL-0008-P-LU 07.08.2023 LU Patent Application
LU10318%
13. A Kit providing an acidic composition according to claims 1 to 12, wherein the kit + comprises at least: oo i. afirst container providing a first component according to any claims 1, 2-4, fy ond ii. a second container providing a second component according to any claim 1, 5 = ® or 6, > characterized in that ee the composition provided by the kit is leavening agent-, GMO- and coating-free and reduces food-borne toxins produced during thermal processing of food-items, preferably in a temperature range between 80 and 400°C, when applied.
14. A method for preparing the composition according to any of the claims 1 to 12, wherein i. a first component according to any claim 1, 2-4,
ii. a second component, according to any claim 1, 4 or 5, individually or as a mixture is then added,
iii. then the first and second components and preferably additional components are blended at room temperature.
15. A method of preparing thermally treated food-items having reduced levels of food- borne toxins, wherein the food-item is treated with a composition according to any one of claims 1 to 12, either by mixing the food items with the composition and/or by soaking the food-items in a liquid composition according to claim 12 prior to thermal treatment, preferably but not limited to heating, boiling, frying and/or roasting.
16. The use of a composition according to claims 1 to 12 and/or a kit according to claim 13, wherein said composition and/or kit is brought into solution in order to be absorbed by food prior to thermal processing.
17. The use of a composition according to claims 1 to 12 and/or a kit according to claim 13 in bakery and extruded products including breads, wafers, crackers, cookies, biscuits, breakfast cereals and rusks. white ip | Patent & Legal BRAL-0008-P-LU 07.08.2023 LU Patent Application
18. The use of a composition according to claims 1 to 12 and/or a kit according to claim LU10318% TH 13 in vegetable-based, legume-based, nut-based, and fruit-based products including S potatoes and olives. os Lan CN Oo
19. The use of a composition according to claims 1 to 12 and/or a kit according to claim Bw 13 in hot and cold beverages and syrup-like substances including coffee, fruit juices, = S Nd alcoholic beverages, and honey. SN De ue white ip | Patent & Legal BRAL-0008-P-LU 07.08.2023 LU Patent Application
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU103185A LU103185B1 (en) | 2023-08-07 | 2023-08-07 | Gmo-free composition of reduction of food-borne toxins and production method thereof |
| PCT/EP2024/072354 WO2025032134A1 (en) | 2023-08-07 | 2024-08-07 | Acidic dry free-flowing food-borne toxin reducing composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU103185A LU103185B1 (en) | 2023-08-07 | 2023-08-07 | Gmo-free composition of reduction of food-borne toxins and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU103185B1 true LU103185B1 (en) | 2025-02-07 |
Family
ID=87800855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU103185A LU103185B1 (en) | 2023-08-07 | 2023-08-07 | Gmo-free composition of reduction of food-borne toxins and production method thereof |
Country Status (2)
| Country | Link |
|---|---|
| LU (1) | LU103185B1 (en) |
| WO (1) | WO2025032134A1 (en) |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004075655A2 (en) | 2003-02-21 | 2004-09-10 | Frito-Lay North America, Inc. Formerly Known As Recot, Inc. | Method for reducing acrylamide formation in thermally processed foods |
| JP2005021150A (en) | 2002-12-03 | 2005-01-27 | Toyo Suisan Kaisha Ltd | Method for producing cooked food capable of reducing acrylamide |
| US20050079254A1 (en) | 2003-10-10 | 2005-04-14 | The Procter & Gamble Company | Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce |
| WO2005094591A2 (en) * | 2004-03-31 | 2005-10-13 | Forinnova As | Reduction of acrylamide formation in coffee-based food processing |
| US20070065542A1 (en) * | 2005-09-20 | 2007-03-22 | Board Of Regents, The University Of Texas System | Enhanced solubility of preformed calcium citrate by adding citric acid |
| US20070141225A1 (en) | 2002-09-19 | 2007-06-21 | Elder Vincent A | Method for Reducing Acrylamide Formation |
| US20070166439A1 (en) | 2004-04-05 | 2007-07-19 | Soe Jorn B | Enzymatic process for acrylamide reduction in foodstuffs |
| US20070212450A1 (en) | 2006-03-13 | 2007-09-13 | Purac Biochem B.V. | Food product comprising a mixture of calcium salts or a calcium double salt |
| KR20090062381A (en) | 2007-12-13 | 2009-06-17 | 이화여자대학교 산학협력단 | Furan production inhibitors containing catechins or epicatechins |
| US20120263825A1 (en) * | 2009-11-25 | 2012-10-18 | Basf Se | Process for producing baked goods |
| CN106819754A (en) * | 2017-03-17 | 2017-06-13 | 西华师范大学 | A kind of suppression No. 100 methods of orange juice brown stain of brocade orange |
| KR101832714B1 (en) * | 2017-07-18 | 2018-02-27 | 서병옥 | Manufacturing method of pickled radish |
| DE102019113073A1 (en) | 2019-05-17 | 2020-11-19 | Addcon GmbH | Process for reducing the amount of acrylamide during the heat treatment of foods with a raising agent effect |
| KR102234633B1 (en) | 2014-04-16 | 2021-04-02 | 이화여자대학교 산학협력단 | Furan reduction method in food |
| WO2022258807A1 (en) | 2021-06-10 | 2022-12-15 | Brendler Lucas | Carboxylic acid loaded salt carrier and the method for producing thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2074890B1 (en) * | 2007-12-21 | 2014-11-26 | Jungbunzlauer Ladenburg GmbH | Method for reducing the acrylamide content of food containing carbohydrates |
| US20130052315A1 (en) * | 2011-08-24 | 2013-02-28 | Pepsico, Inc. | Methods and Compositions for Protecting Beverages From Heat and Light Stress |
| EP3973780A1 (en) * | 2020-09-24 | 2022-03-30 | Glanbia Ireland Dac | A method of preparing a ready-to-consume food product |
| CN113598209B (en) * | 2021-08-08 | 2024-04-02 | 浙江省农业科学院 | Method for reducing acrylamide content in baked food and food additive composition used in same |
-
2023
- 2023-08-07 LU LU103185A patent/LU103185B1/en active IP Right Grant
-
2024
- 2024-08-07 WO PCT/EP2024/072354 patent/WO2025032134A1/en active Pending
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070141225A1 (en) | 2002-09-19 | 2007-06-21 | Elder Vincent A | Method for Reducing Acrylamide Formation |
| JP2005021150A (en) | 2002-12-03 | 2005-01-27 | Toyo Suisan Kaisha Ltd | Method for producing cooked food capable of reducing acrylamide |
| WO2004075655A2 (en) | 2003-02-21 | 2004-09-10 | Frito-Lay North America, Inc. Formerly Known As Recot, Inc. | Method for reducing acrylamide formation in thermally processed foods |
| US20050079254A1 (en) | 2003-10-10 | 2005-04-14 | The Procter & Gamble Company | Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce |
| WO2005094591A2 (en) * | 2004-03-31 | 2005-10-13 | Forinnova As | Reduction of acrylamide formation in coffee-based food processing |
| US20070166439A1 (en) | 2004-04-05 | 2007-07-19 | Soe Jorn B | Enzymatic process for acrylamide reduction in foodstuffs |
| US20070065542A1 (en) * | 2005-09-20 | 2007-03-22 | Board Of Regents, The University Of Texas System | Enhanced solubility of preformed calcium citrate by adding citric acid |
| US20070212450A1 (en) | 2006-03-13 | 2007-09-13 | Purac Biochem B.V. | Food product comprising a mixture of calcium salts or a calcium double salt |
| KR20090062381A (en) | 2007-12-13 | 2009-06-17 | 이화여자대학교 산학협력단 | Furan production inhibitors containing catechins or epicatechins |
| US20120263825A1 (en) * | 2009-11-25 | 2012-10-18 | Basf Se | Process for producing baked goods |
| KR102234633B1 (en) | 2014-04-16 | 2021-04-02 | 이화여자대학교 산학협력단 | Furan reduction method in food |
| CN106819754A (en) * | 2017-03-17 | 2017-06-13 | 西华师范大学 | A kind of suppression No. 100 methods of orange juice brown stain of brocade orange |
| KR101832714B1 (en) * | 2017-07-18 | 2018-02-27 | 서병옥 | Manufacturing method of pickled radish |
| DE102019113073A1 (en) | 2019-05-17 | 2020-11-19 | Addcon GmbH | Process for reducing the amount of acrylamide during the heat treatment of foods with a raising agent effect |
| WO2022258807A1 (en) | 2021-06-10 | 2022-12-15 | Brendler Lucas | Carboxylic acid loaded salt carrier and the method for producing thereof |
Non-Patent Citations (1)
| Title |
|---|
| TOMÁS KOMPRDA ET AL: "A combination of additives can synergically decrease acrylamide content in gingerbread without compromising sensory quality : Decreasing acrylamide content in gingerbread", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 97, no. 3, 14 June 2016 (2016-06-14), GB, pages 889 - 895, XP055398919, ISSN: 0022-5142, DOI: 10.1002/jsfa.7811 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025032134A1 (en) | 2025-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12252674B2 (en) | Preparation of a powdered vinegar | |
| KR100833774B1 (en) | Method for reducing acrylamide formation in thermally processed foods | |
| KR100921599B1 (en) | How to Improve Acrylamide Degradation | |
| AU2005280231B2 (en) | Method for reducing acrylamide formation in thermally processed foods | |
| RU2522521C2 (en) | Iron-containing instant noodles fried in oil and such noodles production method | |
| LU103185B1 (en) | Gmo-free composition of reduction of food-borne toxins and production method thereof | |
| US10005670B2 (en) | Calcium polyphosphate salt particles and method of making | |
| JP2004242571A (en) | Ph adjuster aqueous solution for noodle boiling liquid and noodle processed food using the same | |
| US10165789B2 (en) | Acerola powder for use as a substitute for ascorbic acid in the agri-food field | |
| WO2023037952A1 (en) | Acetic-acid-containing powder | |
| US20120064217A1 (en) | Food additive | |
| JP2007306893A (en) | Processed salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Effective date: 20250207 |